Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients - Medical Xpress
Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients Medical Xpress
Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who had EGFR-mutant ...
Comments
Post a Comment